Noveris Health Sciences (MYCOF) Stock Price, Quote, News & History

Noveris Health Sciences Inc (MYCOF) Stock Price, Quote, News & History

MYCOFOTCPK

Trade with Public

$0.6430

0.51391.59%

Last update: Mar 16, 1:16 PM

Key Statistics

Open

$0.64

Volume / Avg.

1.00K / 245.00

Day Range

$0.64 - $0.64

52 Wk Range

0.00 - 0.30

Market Cap

$794.14K

P/E Ratio

0.08

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Noveris Health Sciences Inc News

Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs

Novel psychedelic-based drugs biotech Mydecine Innovations Group (OTC: MYCOF) shared its financial results for the six months ended June 30, 2023. Second quarter of FY2023 looks like this: Cash position of $29.987 (CA $40,458) as of June 30, 2023.

Lara Goldstein

Mydecine's Prospectus Supplement Closing Under Share Subscription And Management Update

Colorado-based next-generation psychedelics biotech Mydecine Innovations Group Inc. (OTC: MYCOF) announced that, in connection with its common share subscription agreement with a third-party investor dated this past March 10, it has filed a shelf prospectus supplement to its final base shelf prospectus for th

Lara Goldstein

Mydecine's Q1 2023 Reports Shows Decline In Assets And R&D, Increase In Net Loss And Accumulated Deficit

Psychedelics biotech Mydecine Innovations Group (OTC: MYCOF) shared its condensed interim (unaudited) financial results for three months ended March 31, 2023. First quarter numbers:

Lara Goldstein

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-13.09K

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

Free Cash Flow (TTM)

-13.09K

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-13.09K

Valuation Metrics

Enterprise Value

$5.44M

PE Ratio (TTM)

0.08

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

1191.48%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

2.63

Price / EBITDA (TTM)

0.08

Price / Free Cash Flow (TTM)

Book Value / Share

-$9.02

Company Debt

Total Debt

$6.94M

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$47.08K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.64

Volume / Avg.

1.00K / 245.00

Day Range

$0.64 - $0.64

52 Wk Range

0.00 - 0.30

Market Cap

$794.14K

P/E Ratio

0.08

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Noveris Health Sciences Inc, formerly Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Noveris Health Sciences (MYCOF) stock?

You can purchase shares of Noveris Health Sciences (OTCPK:MYCOF) through any online brokerage.

View our list of the best stock brokerages

Who are Noveris Health Sciences (MYCOF) competitors?

There are no as such competitors for Noveris Health Sciences.

What is the forecast, or price target, for Noveris Health Sciences (MYCOF) stock?

There is no analysis for Noveris Health Sciences to provide a consensus price target.

What is the current price for Noveris Health Sciences (MYCOF)?

The stock price for Noveris Health Sciences (OTCPK: MYCOF) is $0.643 last updated March 16, 2026 at 1:16 PM EDT.

Does Noveris Health Sciences (MYCOF) pay a dividend?

There are no upcoming dividends for Noveris Health Sciences.

When is Noveris Health Sciences (OTCPK:MYCOF) reporting earnings?

Noveris Health Sciences does not have any upcoming earnings scheduled.

Is Noveris Health Sciences (MYCOF) going to split?

There is no upcoming split for Noveris Health Sciences.

What sector and industry does Noveris Health Sciences (MYCOF) operate in?

Noveris Health Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.

Key Statistics

Open

$0.64

Volume / Avg.

1.00K / 245.00

Day Range

$0.64 - $0.64

52 Wk Range

0.00 - 0.30

Market Cap

$794.14K

P/E Ratio

0.08

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Noveris Health Sciences Inc News

Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs

Lara Goldstein

Mydecine's Prospectus Supplement Closing Under Share Subscription And Management Update

Lara Goldstein

Mydecine's Q1 2023 Reports Shows Decline In Assets And R&D, Increase In Net Loss And Accumulated Deficit

Psychedelics biotech Mydecine Innovations Group (OTC: MYCOF) shared its condensed interim (unaudited) financial results for three months ended March 31, 2023. First quarter numbers:

Lara Goldstein